Method helps identify preperimetric glaucoma

Article

The Random Forests machine learning method is a useful tool to help ophthalmologists distinguish between the visual fields (VFs) of individuals with healthy eyes and those with preperimetric open-angle glaucoma (OAG) in which glaucoma will manifest, according to research from Japan.

The Random Forests machine learning method is a useful tool to help ophthalmologists distinguish between the visual fields (VFs) of individuals with healthy eyes and those with preperimetric open-angle glaucoma (OAG) in which glaucoma will manifest, according to research from Japan published in Investigative Ophthalmology & Visual Science.

The investigators classified all VFs before an initial diagnosis of manifest glaucoma as preperimetric glaucoma VFs. They used the 30-2 threshold test programme of an automated perimeter (Humphrey Field Analyzer, Carl Zeiss Meditec) to obtain a series of 171 VFs in 53 eyes of 51 individuals with OAG or suspected OAG and from 108 healthy eyes of 87 individuals. They used the Random Forests method to calculate the area under the receiver operating characteristic curve (AROC) in distinguishing between the VFs of those with preperimetric glaucoma and those with healthy eyes; they used 52 total deviation (TD) values, mean deviation (MD) and pattern standard deviation (PSD) as predictors.

The researchers found a significant difference in MD and PSD between VFs of those with healthy eyes and the VFs of those with eyes with preperimetric glaucoma. They also observed a significant difference in the TD values between healthy VFs and preperimetric VFs at 25 out of 52 test points. The AROC obtained using the Random Forests method was 79%.

To read the study, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.